Islet cell engraftment and control of diabetes in rats after transplantation of pig pancreatic anlagen

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 4 49-4, 2004, Pages

  Rogers, Sharon A ^a   Chen, Feng ^a   Talcott, Mike ^a   Hammerman, Marc R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cell; cell; Insulin; Xenotransplantation

Indexed keywords

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; EMBRYO; GLUCOSE TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; OMENTUM; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RAT; SWINE; TISSUE DIFFERENTIATION; XENOGRAFT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCOSE TOLERANCE TEST; IMMUNOSUPPRESSION; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; OMENTUM; PREGNANCY; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SWINE; TRANSPLANTATION, HETEROLOGOUS; WEIGHT GAIN;

EID: 1642364243     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00445.2003     Document Type: Article

References (28)

1. Adams GA, Squires EC, Mastri M, Lee L, Alfrey EJ, and Dafoe DC. Regimens of IGF-1 treatment in fetal pancreas transplantation. J Surg Res 68: 73-78, 1997.
2. Alumets J, Hakanson R, and Sundler F. Ontogeny of endocrine cells in porcine gut and pancreas. Gastroenterology 85: 1359-1372, 1983.
3. Bonner-Weir S. β-Cell turnover: its assessment and implications. Diabetes 50, Suppl 1: S20-S24, 2001.
4. Brown J, Clark WR, Molnar IG, and Mullen YS. Fetal pancreas transplantation for reversal of streptozotocin-induced diabetes in rats. Diabetes 25: 56-64, 1976.
5. Brown J, Danilovs JA, Clark WR, and Mullen YS. Fetal pancreas as a donor organ. World J Surg 8: 152-157, 1984.
6. Brown J, Mullen YS, Clark WR, Molnar G, and Heinsinger D. Importance of hepatic portal circulation for insulin action in streptozotocin-diabetic rats transplanted with fetal pancreases. J Clin Invest 64: 1688-1694, 1979.
7. Castaing M, Peault B, Basmacciogullari A, Czernichow P, and Schnarfman R. Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice. Diabetologia 44: 2066-2076, 2001.
8. DiFiore MSH. Atlas of Human Histology (3rd ed.). Philadelphia, PA: Lea & Febiger, 1968, p. 33.
9. Du Toit D, Muller C, Page B, and Louw J. Foetal rat pancreatic transplantation: posttransplantation development of foetal pancreatic iso- and allografts and suppression of rejection with mycophenolate mofetil (MMF) and cyclosporine based immunesuppression. Microsc Res Tech 43: 347-355, 1998.
10. Garcia-Ocana A, Takane KK, Syed MA, Philbrick WM, Vasavada RC, and Stewart AF. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass and induces mild hypoglycemia. J Biol Chem 275: 1226-1232, 2000.
11. Gerich JE. Treatment of diabetes mellitus. In Endocrinology (2nd ed.), edited by DeGroot LJ, Bessler GM, Cahill GF, Marshall JC, Nelson DH, Odell WD, Potts JT Jr, Rubenstein AH, Steinberger L, and Martinin L. Philadelphia, PA: Saunders, 1989, p. 1429.
12. Groth CG, Korsgren O, Tibell A, Tollemar J, Moller E, Bolinder J, Ostman J, Reinholt FR, Hellerstrom C, and Andersson A. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344: 1402-1404, 1994.
13. Hammerman MR. Xenotransplantation of developing kidneys. Am J Physiol Renal Physiol 283: F601-F606, 2002.
14. Hegre OD, Leonard RL, Erlandsen SL, McEvoy JA, Elde RP, and Lazarow A. Transplantation of islet tissue in the rat. Acta Endocrinol, Suppl 205: 257-278, 1976.
15. Hegre OD, Leonard RJ, Schmitt BA, and Lazarow A. Isotransplantation of organ-cultured neonatal pancreas: reversal of alloxan diabetes in the rat. Diabetes 25: 180-189, 1976.
16. Hegre OD, Schmidt RV, and McEvoy RC. Syngeneic transplantation of the fetal rat pancreas. IV. Dissociated versus whole organ implantation. Metabolism 28: 157-162, 1979.
17. Hoet JJ and Remacle C. Organization of the pancreatic islets with special reference to diabetes. In: Endocrinology (2nd ed.), edited by DeGroot LJ, Bessler GM, Cahill GF, Marshall JC, Nelson DH, Odell WD, Potts JT Jr, Rubenstein AH, Steinberger L, and Martinin L. Philadelphia, PA: Saunders, 1989, p. 1248-1252.
18. Korsgren O and Jansson L. Discordant cellular xenografts revascularized in intermediate athymic hosts fail to induce a hyperacute rejection when transplanted into immunocompetent rats. Transplantation 57: 1408-1411, 1994.
19. Lammert E, Cleaver O, and Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science 294: 564-567, 2001.
20. Mandel TE. Fetal islet xenotransplantation in rodents and primates. J Molec Med 77: 55-160, 1999.
21. Rogers SA, Liapis H, and Hammerman MR. Intraperitoneal transplantation of pancreatic anlagen. ASAIO J 49: 527-532, 2003.
22. Rogers SA, Talcott M, and Hammerman MR. Transplantation of pig metanephroi. ASAIO J 49: 48-52, 2003.
23. Sachs DH. The pig as a potential xenograft donor. Vet Immunol Immunopathol 43: 85-191, 1994.
24. Sheehan DC and Hrapchak BB. Theory and Practice of Histotechnology. Columbus, OH: Battelle, 1980, p. 272-273.
25. Shintaku IP and Mullen Y. Fetal pancreas allografts for reversal of diabetes in rats. Transplantation 29: 35-42, 1980.
26. Thivolet C. New therapeutic approaches to type 1 diabetes: from prevention to cellular or gene therapies. Clin Endocrinol 55: 565-574, 2001.
27. Unger RH and Orci L. Glucagon secretion and metabolism in man. In: Endocrinology (2nd ed.), edited by DeGroot LJ, Bessler GM, Cahill GF, Marshall JC, Nelson DH, Odell WD, Potts JT Jr, Rubenstein AH, Steinberger L, and Martinin L. Philadelphia, PA: Saunders, 1989, p. 1321.
28. Wennberg L, Song Z, Bennet W, Zhang J, Nava S, Sundberg B, Bari S, Groth CG, and Korsgren O. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil and leflunomide remain normoglycemic for up to 100 days. Transplantation 71: 1024-1033, 2001.